Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial
- DOI
- 10.1016/j.intimp.2021.108043
- Published
- 2021-10
- Container
- International Immunopharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2021.108043,
title = {Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial},
author = {Saghar Barati and Seyed MohammadReza Hashemian and Payam Tabarsi and Atefeh Abedini and Mahshid Ashrafzadeh and Sara Haseli and Zahra Abtahian and Sahar Yousefian and Alireza Dastan and Ali Sobhanian and Farzaneh Dastan},
year = {2021},
journal = {International Immunopharmacology},
doi = {10.1016/j.intimp.2021.108043},
url = {https://doi.org/10.1016/j.intimp.2021.108043}
}RIS
TY - JOUR TI - Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial AU - Saghar Barati AU - Seyed MohammadReza Hashemian AU - Payam Tabarsi AU - Atefeh Abedini AU - Mahshid Ashrafzadeh AU - Sara Haseli AU - Zahra Abtahian AU - Sahar Yousefian AU - Alireza Dastan AU - Ali Sobhanian AU - Farzaneh Dastan PY - 2021 JO - International Immunopharmacology DO - 10.1016/j.intimp.2021.108043 UR - https://doi.org/10.1016/j.intimp.2021.108043 ER -
APA
Barati, S., Hashemian, S. M., Tabarsi, P., Abedini, A., Ashrafzadeh, M., Haseli, S., Abtahian, Z., Yousefian, S., Dastan, A., Sobhanian, A., & Dastan, F. (2021). Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2021.108043
Source records
- crossref · retrieved 2026-09-27T01:31:10.161Z